Australia

Australia has cancelled the citizenship of an Algerian-born Muslim cleric convicted of planning a series of terror attacks in 2005. Abdul Nacer Benbrika was jailed for 15 years in 2009 and is eligible for release from next month. But Home...

International air travellers will in future need to prove they have been vaccinated against Covid-19 in order to board Qantas flights, the airline says. The Australian flag carrier's boss, Alan Joyce, said the move would be "a necessity" when vaccines...

South Australia decided to enter a state-wide lockdown based on a lie told by a man with Covid-19 about his link to a pizza shop, police say. The strict lockdown began on Wednesday after the state detected 36 infections, including...

There is "credible evidence" that Australian special forces unlawfully killed 39 people during the Afghan conflict, a long-awaited report has found. The Australian Defence Force (ADF) has released findings from a four-year inquiry into misconduct by its forces. The inquiry...

Kazia Therapeutics Ltd (ASX:KZA) is making steady progress in advancing its investigational new drug, paxalisib, executing an agreement last week to participate in the GBM AGILE pivotal study in glioblastoma. GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) is an international platform study that has been established specifically to facilitate the approval of new medicines for glioblastoma, an aggressive type of cancer that can occur in the brain or spinal cord. The study is set to move into an operational phase with recruitment of patients to the paxalisib arm expected to begin in the first quarter of 2021. Corporate Connect Research has initiated coverage on Kazia with a 12-month price target of $2.05 (current share price: 85 cents). The following is an extract from Corporate Connect’s initiation report: Since August 1st, Kazia Therapeutics has announced US Food & Drug Administration fast track status for one program & orphan drug and rare paediatric dise..

Emyria Ltd’s (ASX:EMD) clinical operations subsidiary, Emerald Clinics, has entered into a global partnership with UK-based Sapphire Medical Clinics. The partnership will provide a new source of data to bolster Emyria’s growing cannabinoid data platform and allow Emyria to leverage Sapphire’s resources and infrastructure in the UK to provide services to UK patients. Support clinical service in UK[hhmc] Emyria managing director Dr Michael Winlo said: “Access to medicinal cannabis in the UK is restricted in similar ways to how access was restricted in Australia a few years ago. “We know that regulators in Australia and the UK encourage registration of medicinal cannabis and that this requires high-quality clinical evidence. “This agreement is part of an evolving partnership between our two organisations which will allow us to support a clinical service in the UK while also collecting high quality de-identified clinical evidence that can greatly enhance the utility and value of our E..

Cellmid Limited (ASX:CDY) has made changes to its board and senior management following the divestment of its Lyramid biotech assets to focus on the Advangen consumer health business. Sarah Eck-Thompson is a consumer brand specialist with expertise in experiential marketing and has been nominated as alternate director to Dennis Eck, her father, effective November 30, 2020. Independent director Dr Fintan Walton will retire by rotation at the Annual General Meeting on November 30, 2020, and will not stand for re-election while Lyramid CEO Bart Wuurman has resigned effective November 30, having completed his mandate to develop the strategy and prepare the company for divestment. “Instrumental in transformation”[hhmc] Cellmid’s independent chairman Dr David King has advised the company of his intention to resign from the board, and will consequently not stand for re-election at the AGM. Cellmid chief executive officer Maria Halasz said: “David has been instrumental in Cellmid’s transfo..

Strickland Metals Ltd (ASX:STK) shares surged 39% today ahead of its maiden drilling program at the Doolgunna Project, which will include a diamond drilling program that is likely to begin by the end of this month. As a part of the program, a minimum of four diamond holes will be drilled to a depth of 500 metres to test a VMS target similar to the nearby DeGrussa deposit of Sandfire Resources (ASX:SFR). Heritage survey[hhmc] Exploration activity has recommenced on the Doolgunna Project following completion of heritage surveys to allow land access to areas where the company wishes to complete exploration drilling. The target for drilling is a compelling base metal prospect that exhibits geological characteristics that are interpreted to be similar to Sandfire Resources’ DeGrussa deposit about 30 kilometres to the east of the project. The prospect has a 3-kilometre-long electromagnetic conductor that lies below an outcropping copper-zinc gossan that has been mapped over a 1.2-kilomet..

Argonaut Resources NL (ASX:ARE) directors have demonstrated their faith in the company’s copper-zinc strategy by participating in the recently closed share purchase plan (SPP). Independent non-executive chairman Patrick Elliot purchased more than 4.465 million shares at 0.55 cents per share in an indirect interest. He now holds 5,876,159 shares in that interest with another 20,324,574 held in a separate indirect interest. Independent non-executive chairman Malcolm Richmond acquired more than 5.454 million shares in a direct interest, increasing the number held in this interest to almost 15 million with another 1 million held in an indirect interest. Overwhelming response to SPP[hhmc] The company was overwhelmed by the response to its SPP which closed early and more than twice oversubscribed with the target subsequently increased to $2.5 million from $1.2 million. Subscriptions in excess of $3 million were received and as a result, the SPP was closed with immediate effect. Money ..

Pan Asia Metals Ltd (ASX:PAM) has had positive discussions with authorities in Phang Nga Province, Thailand, including the provincial government, for its Reung Kiet Lithium Project. PAM has submitted a presentation covering all aspects of the project including methods of ongoing exploration, conceptual mining and concentrate production, and the potential for downstream value-adding industries in Phang Nga and Thailand. The presentation and subsequent discussions were aimed at assisting Phang Nga Provincial Government in their considerations for the proposed mining and industrial development areas. Provincial Government discussions[hhmc] Pan Asia was recently invited by the chief executive officer of the Phang Nga Provincial Administrative Organisation (PAO), a Phang Nga Provincial Government coordinating body, to represent PAM and the Reung Kiet Lithium Project. The meeting was also attended by the head of Phang Nga Provincial Industry along with the representatives of the Phang Ng..